DNAprint Genomics (DNAG)

[cosmiclifeform]

DougS - Great example of exactly the value of DNAP's Statinome...to eliminate or minimize the risks of death or physical dysfunction from statins...(and of course minimize the legal fees and keep the profits inhouse)...

And considering Astra's statement that they need Crestor (Rosuvastatin) "to drive future profits", one could surmise that expedient, cost-savings (and face-savings) alternatives would be looked at...as quickly as possible..ie, DNAP's revolutionary and cost-effective ADMIXMAP pan-genome screening platform.

Not sure of DNAP's current genotyping service fees, but it was stated earlier that all Astra needs for a clinical study is $200,000 and Astra will have their answer in 6 months (not two years or more). Definitely a great example where DNAP could help "Big Pharma" save themselves millions of $$, maybe more.

Astra has alot to lose (viz Bayor's recent withdrawal of their profit-making drug)...and, using DNAP's technology...alot to gain.

...Of course this is just another one of those "it would be nice"... Keeping the dreams alive...lol!

God Bless and take care,

Robert